$208 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 65 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 112.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LBIO | Buy | LION BIOTECHNOLOGIES INC | $26,183,000 | +106.2% | 3,232,416 | +29.3% | 12.58% | +77.2% |
| VCYT | Buy | VERACYTE INC | $16,034,000 | +8.5% | 3,187,607 | +16.5% | 7.70% | -6.8% |
| IRIX | Buy | IRIDEX CORP | $14,966,000 | +122.7% | 1,011,871 | +53.9% | 7.19% | +91.4% |
| Sell | NEURODERM LTD | $10,303,000 | -11.7% | 634,000 | -23.3% | 4.95% | -24.2% | |
| IMMU | Sell | IMMUNOMEDICS INC | $9,744,000 | -29.5% | 4,200,000 | -24.0% | 4.68% | -39.4% |
| RRM | Buy | RR MEDIA LTD | $7,996,000 | +0.6% | 611,818 | +0.6% | 3.84% | -13.5% |
| EVDY | Buy | EVERYDAY HEALTH INC | $7,447,000 | +61.3% | 945,000 | +14.6% | 3.58% | +38.6% |
| CASM | Buy | CAS MED SYS INC | $6,441,000 | +69.3% | 3,500,602 | +30.7% | 3.10% | +45.5% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $6,342,000 | -70.0% | 1,161,545 | -53.5% | 3.05% | -74.2% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $6,274,000 | -45.8% | 472,800 | -24.2% | 3.02% | -53.4% |
| IWM | ISHARES TRput | $5,749,000 | +3.9% | 50,000 | 0.0% | 2.76% | -10.7% | |
| EDGE | Buy | EDGE THERAPEUTICS INC | $5,358,000 | +52.0% | 530,000 | +37.6% | 2.58% | +30.6% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $4,979,000 | – | 64,000 | +100.0% | 2.39% | – |
| DERM | New | DERMIRA INC | $4,973,000 | – | 170,000 | +100.0% | 2.39% | – |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $4,488,000 | +28.9% | 600,000 | +55.3% | 2.16% | +10.8% |
| NBRV | Buy | NABRIVA THERAPEUTICS AGsponsored adr | $4,191,000 | -14.2% | 558,771 | +2.5% | 2.01% | -26.3% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $3,756,000 | +23.0% | 417,278 | +35.5% | 1.80% | +5.7% |
| Buy | IMMUNOMEDICS INCnote 4.750% 2/1 | $3,733,000 | +77.1% | 5,500,000 | +83.3% | 1.79% | +52.2% | |
| CEMP | CEMPRA INC | $3,463,000 | -5.9% | 210,000 | 0.0% | 1.66% | -19.1% | |
| INNL | Buy | INNOCOLL HLDGS PLC | $3,130,000 | -3.4% | 568,137 | +50.4% | 1.50% | -17.0% |
| MDVN | New | MEDIVATION INC | $3,015,000 | – | 50,000 | +100.0% | 1.45% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $2,792,000 | – | 85,999 | +100.0% | 1.34% | – |
| TSRO | New | TESARO INC | $2,522,000 | – | 30,000 | +100.0% | 1.21% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $2,479,000 | – | 130,000 | +100.0% | 1.19% | – |
| MRVL | New | MARVELL TECHNOLOGY GROUP LTDord | $2,283,000 | – | 239,588 | +100.0% | 1.10% | – |
| PODD | New | INSULET CORP | $2,268,000 | – | 75,000 | +100.0% | 1.09% | – |
| INSM | New | INSMED INC | $2,169,000 | – | 220,000 | +100.0% | 1.04% | – |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $2,111,000 | +50.1% | 300,000 | +81.4% | 1.01% | +29.0% |
| AGN | New | ALLERGAN PLC | $1,964,000 | – | 8,500 | +100.0% | 0.94% | – |
| CYNA | Sell | CYNAPSUS THERAPEUTICS INC | $1,933,000 | -72.5% | 115,400 | -80.5% | 0.93% | -76.4% |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $1,909,000 | – | 42,000 | +100.0% | 0.92% | – |
| PGNX | Buy | PROGENICS PHARMACEUTICALS IN | $1,894,000 | +86.6% | 448,885 | +92.8% | 0.91% | +60.2% |
| RTRX | Sell | RETROPHIN INC | $1,759,000 | -35.6% | 98,788 | -50.6% | 0.84% | -44.7% |
| Buy | ESSA PHARMA INC | $1,754,000 | +15.1% | 570,232 | +22.0% | 0.84% | -1.1% | |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $1,667,000 | +3.2% | 747,748 | -3.7% | 0.80% | -11.4% |
| ATRC | New | ATRICURE INC | $1,596,000 | – | 112,923 | +100.0% | 0.77% | – |
| SRPT | New | SAREPTA THERAPEUTICS INCcall | $1,526,000 | – | 80,000 | +100.0% | 0.73% | – |
| WBMD | New | WEBMD HEALTH CORP | $1,453,000 | – | 25,000 | +100.0% | 0.70% | – |
| CYTK | New | CYTOKINETICS INC | $1,338,000 | – | 140,969 | +100.0% | 0.64% | – |
| SGY | New | STONE ENERGY CORPput | $1,304,000 | – | 108,100 | +100.0% | 0.63% | – |
| GHDX | New | GENOMIC HEALTH INC | $1,264,000 | – | 48,800 | +100.0% | 0.61% | – |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $1,251,000 | – | 225,444 | +100.0% | 0.60% | – |
| RXDX | New | IGNYTA INC | $1,245,000 | – | 229,748 | +100.0% | 0.60% | – |
| ALIM | ALIMERA SCIENCES INC | $1,198,000 | -29.7% | 974,318 | 0.0% | 0.58% | -39.6% | |
| OLED | Sell | UNIVERSAL DISPLAY CORP | $1,017,000 | -73.1% | 15,000 | -78.6% | 0.49% | -76.9% |
| RPTP | New | RAPTOR PHARMACEUTICAL CORP | $938,000 | – | 174,708 | +100.0% | 0.45% | – |
| ONS | New | ONCOBIOLOGICS INC | $828,000 | – | 243,391 | +100.0% | 0.40% | – |
| SVA | New | SINOVAC BIOTECH LTD | $786,000 | – | 132,503 | +100.0% | 0.38% | – |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $683,000 | -69.1% | 125,000 | +21.0% | 0.33% | -73.5% |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $654,000 | – | 50,000 | +100.0% | 0.31% | – |
| BEAT | New | BIOTELEMETRY INC | $564,000 | – | 34,630 | +100.0% | 0.27% | – |
| AKTX | Buy | AKARI THERAPEUTICS PLCsponsored adr | $446,000 | +89.0% | 33,077 | +81.2% | 0.21% | +62.1% |
| CDNA | New | CAREDX INC | $279,000 | – | 64,627 | +100.0% | 0.13% | – |
| TROV | New | TROVAGENE INCput | $236,000 | – | 52,000 | +100.0% | 0.11% | – |
| DXTRQ | New | DEXTERA SURGICAL INC | $232,000 | – | 128,958 | +100.0% | 0.11% | – |
| CYTR | New | CYTRX CORPput | $223,000 | – | 100,000 | +100.0% | 0.11% | – |
| AUDC | New | AUDIOCODES LTDord | $189,000 | – | 45,035 | +100.0% | 0.09% | – |
| RLYP | New | RELYPSA INCcall | $185,000 | – | 10,000 | +100.0% | 0.09% | – |
| CBMX | COMBIMATRIX CORPORATION | $136,000 | -20.5% | 47,431 | 0.0% | 0.06% | -32.3% | |
| IMMU | New | IMMUNOMEDICS INCcall | $136,000 | – | 58,600 | +100.0% | 0.06% | – |
| MNKD | Sell | MANNKIND CORPput | $104,000 | -57.0% | 90,000 | -40.0% | 0.05% | -63.0% |
| CEMI | New | CHEMBIO DIAGNOSTICS INC | $100,000 | – | 12,180 | +100.0% | 0.05% | – |
| ONSIW | New | ONCOBIOLOGICS INC*w exp 02/18/201 | $45,000 | – | 96,833 | +100.0% | 0.02% | – |
| ONSIZ | New | ONCOBIOLOGICS INC*w exp 05/18/201 | $44,000 | – | 96,833 | +100.0% | 0.02% | – |
| PTX | New | PERNIX THERAPEUTICS HLDGS INput | $28,000 | – | 62,800 | +100.0% | 0.01% | – |
| NVIV | Exit | INVIVO THERAPEUTICS HLDGS COput | $0 | – | -20,000 | -100.0% | -0.08% | – |
| EYES | Exit | SECOND SIGHT MED PRODS INCput | $0 | – | -50,000 | -100.0% | -0.14% | – |
| CRDC | Exit | CARDICA INC | $0 | – | -120,958 | -100.0% | -0.24% | – |
| Exit | AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $0 | – | -1,000,000 | -100.0% | -0.28% | – | |
| TLGT | Exit | TELIGENT INC NEW | $0 | – | -103,411 | -100.0% | -0.28% | – |
| Exit | ENDOLOGIX INCnote 2.250% 12/1 | $0 | – | -796,000 | -100.0% | -0.32% | – | |
| EXEL | Exit | EXELIXIS INC | $0 | – | -320,897 | -100.0% | -0.72% | – |
| Exit | IGI LABORATORIES INCnote 3.750% 12/1 | $0 | – | -4,000,000 | -100.0% | -1.78% | – | |
| SBBP | Exit | STRONGBRIDGE BIOPHARMA PLC | $0 | – | -1,063,747 | -100.0% | -2.52% | – |
| CPXX | Exit | CELATOR PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -3.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.